Literature DB >> 28073369

High body mass index in rheumatoid arthritis: why we should promote physical activity.

M Hugo1, N Mehsen-Cetre1, A Pierreisnard1, E Pupier1, B Cherifi1, T Schaeverbeke1, V Rigalleau2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28073369      PMCID: PMC5223481          DOI: 10.1186/s13075-016-1209-5

Source DB:  PubMed          Journal:  Arthritis Res Ther        ISSN: 1478-6354            Impact factor:   5.156


× No keyword cloud information.
We were interested in the recent publication of Albrecht et al. on body mass index (BMI) distribution in rheumatoid arthritis (RA) [1]. According to this analysis of three large cohorts, the majority of patients with RA are overweight [1]. Low remission rates and common metabolic syndrome indicate that the increasing BMI in RA should be treated, but weight loss may not be the solution as it has been linked to increased mortality [2]. Working on nutritional status in RA, we had the opportunity to compare the body composition analysis (DEXA) and physical activity levels recorded over 3 days with Actimeters (SenseWear Arm Bands, Body Media, Stanford, CA, USA) in overweight versus normal-weight patients. We feel that our results may help orientate management despite the obesity paradox in RA. As depicted in Table 1, the main characteristics of the patients (age and gender) and their disease (duration, DAS28-ESR, and use of corticosteroids) were similar in the overweight and normal subjects. The rates of rheumatoid cachexia and osteopenia were dramatically reduced in overweight patients. Over the whole group, BMI were positively related to bone mass (r = +0.29, p < 0.05) and the rachis T scores (r = +0.36, p < 0.01). The overweight patients had lower levels of physical activity, and BMI was negatively related to these levels: metabolic equivalent tasks (METs) (r = –0.60, p < 0.001) and daily duration of physical activity (r = –0.41, p < 0.005).
Table 1

Characteristics of patients with rheumatoid arthritis and who were overweight or obese (N = 27) as compared to patients of normal weight (N = 29)

Normal weightOverweight or obese p
Gender (% men)20%21%NS
Age (years)56 ± 1258 ± 9NS
Duration of rheumatoid arthritis (years)6.9 ± 8.37.2 ± 6.6NS
DAS28-ESR3.7 ± 1.74.1 ± 2.0NS
Treated by corticosteroids (%)65%53%NS
Nutritional status
 Body mass index (kg/m2)22.1 ± 2.230.5 ± 6.9<0.0001
 Fat (%)32.1 ± 10.238.0 ± 8.2<0.05
 Fat-free mass index (kg/m2)15.2 ± 1.718.6 ± 2.7<0.001
 Metabolic syndrome (%)10.3%39.3%<0.05
 Rheumatoid cachexia (%)34.5%3.7%<0.01
Bone status
 Bone mass (g)1978 ± 3652223 ± 398<0.05
 Rachis T score–1.1 ± 1.30.0 ± 1.4<0.005
 Osteopenic, rachis (%)66%24%<0.005
 Femoral neck, T score–1.3 ± 1.2–0.6 ± 1.2<0.05
 Osteopenic, femoral (%)74%40%<0.05
Actimetry
 Metabolic equivalent tasks1.52 ± 0.321.24 ± 0.25<0.005
 Duration of physical activity (min/day)109 ± 9959 ± 71<0.05

DAS28-ESR Disease Activity Score in 28 joints-erythrocyte sedimentation rate, NS not significant

Characteristics of patients with rheumatoid arthritis and who were overweight or obese (N = 27) as compared to patients of normal weight (N = 29) DAS28-ESR Disease Activity Score in 28 joints-erythrocyte sedimentation rate, NS not significant The body composition analysis of our overweight patients shows that some of their nutritional characteristics should be preserved by therapeutic intervention: less rheumatoid cachexia, that is known to reduce life expectancy, and less osteopenia, whereas the risk of fractures is doubled in RA [3]. The reduced levels of physical activity in overweight RA patients has been reported using questionnaires [4], but to our knowledge this has not yet been demonstrated with more objective actimetry measurements as we have performed. Improving these low levels of activity should be beneficial for the metabolic syndrome of overweight patients. Exercise is also considered beneficial for osteoporosis and for rheumatoid cachexia. The main limitation of interventions on physical activity is their modest results in terms of weight loss [5], while mortality may be increased by frank and unintentional weight loss in RA [2].
  5 in total

1.  Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis.

Authors:  Joshua F Baker; Erica Billig; Kaleb Michaud; Said Ibrahim; Liron Caplan; Grant W Cannon; Andrew Stokes; Vikas Majithia; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

2.  What predicts obesity in patients with rheumatoid arthritis? An investigation of the interactions between lifestyle and inflammation.

Authors:  A Stavropoulos-Kalinoglou; G S Metsios; J P Smith; V F Panoulas; K M J Douglas; A Z Jamurtas; Y Koutedakis; G D Kitas
Journal:  Int J Obes (Lond)       Date:  2009-10-27       Impact factor: 5.095

3.  Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.

Authors:  T P van Staa; P Geusens; J W J Bijlsma; H G M Leufkens; C Cooper
Journal:  Arthritis Rheum       Date:  2006-10

Review 4.  Pedometer intervention and weight loss in overweight and obese adults with Type 2 diabetes: a meta-analysis.

Authors:  X Cai; S H Qiu; H Yin; Z L Sun; C P Ju; M Zügel; J M Steinacker; U Schumann
Journal:  Diabet Med       Date:  2016-03-25       Impact factor: 4.359

5.  Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases.

Authors:  Katinka Albrecht; Adrian Richter; Johanna Callhoff; Dörte Huscher; Georg Schett; Anja Strangfeld; Angela Zink
Journal:  Arthritis Res Ther       Date:  2016-06-23       Impact factor: 5.156

  5 in total
  2 in total

1.  Sedentary Time, Physical Activity, and Sleep Duration: Associations with Body Composition in Fibromyalgia. The Al-Andalus Project.

Authors:  Blanca Gavilán-Carrera; Pedro Acosta-Manzano; Alberto Soriano-Maldonado; Milkana Borges-Cosic; Virginia A Aparicio; Manuel Delgado-Fernández; Víctor Segura-Jiménez
Journal:  J Clin Med       Date:  2019-08-20       Impact factor: 4.241

2.  Factors Associated with Objectively Measured Physical Activity in Patients with Seropositive Rheumatoid Arthritis.

Authors:  Sandra Haider; Michael Sedlak; Ali Kapan; Igor Grabovac; Thomas Lamprecht; Ludwig Erlacher; Michael Quittan; Karl Heinrich Fenzl; Thomas Ernst Dorner
Journal:  Int J Environ Res Public Health       Date:  2020-12-03       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.